No evidence of differential impact of sunflower and rapeseed oil on biomarkers of coronary artery disease or chronic kidney disease in healthy adults with overweight and obesity: result from a randomised control trial

Table 2 Two-day dietary intake (food diaries) assessed at baseline

	Rapeseed oil (n = 28)	Sunflower (n = 27)	Control (n = 27)	p value¹
	Median (IQR)	Median (IQR)	Median (IQR)	p value¹
Energy (kcal)	1921 (1473–2380)	1795 (1358–2219)	1948 (1641–2285)	0.83
CHO (%E)	46 (42–54)	44 (38–50)	43 (39–48)	0.22
Protein (%E)	15 (13–20)	17 (15–20)	17 (16–19)	0.72
Fat (%E)	35 (30–39)	34 (30–43)	36 (33–40)	0.58
SFA (%E)	14 (11–15)	13 (11–17)	11 (10–15)	0.55
MUFA (%E)	12 (9–13)	10 (8–13)	12 (9–13)	0.40
MUFA (/g fat)	0.34 (0.29–0.37)	0.28 (0.24–0.33)	0.30 (0.26–0.36)	0.10
PUFA (%E)	4 (3–5)	4 (3–5)	5 (3–6)	0.82
PUFA (/g of fat)	0.12 (0.10–0.15)	0.11 (0.09–0.14)	0.13 (0.08–0.17)	0.54
Omega 3 (g)	0.6 (0.3–0.8)	0.6 (0.3–0.9)	0.8 (0.5–1.2)	0.20
Omega 6 (g)	3.6 (2.7–6.5)	2.5 (1.5–4.6)	4.4 (3.0–5.7)	0.10

CHO carbohydrate, SFA saturated fat, MUFA mono-unsaturated fatty acids, PUFA polyunsaturated fatty acids, %E percentage of total energy intake
¹Kruskal-Wallis investigating concentration differences between groups at baseline. 1, 2, 4 participants in RO, SO and control groups respectively did not complete baseline food diaries